|
| | 09900HB1431ham001 | - 2 - | LRB099 07179 JLK 32896 a |
|
|
1 | | that is not individually identifiable as described under HIPAA, |
2 | | as specified in 45 CFR 164.514(b). |
3 | | (f) "Department" means the Illinois Department of Public |
4 | | Health or its designated agents.
|
5 | | (g) "Disclosure" has the meaning ascribed to it under |
6 | | HIPAA, as specified in 45 CFR 160.103. |
7 | | (h) "Health care operations" has the meaning ascribed to it |
8 | | under HIPAA, as specified in 45 CFR 164.501. |
9 | | (i) "Health care professional" means (i) a licensed |
10 | | physician, (ii) a
physician assistant
to whom the physician |
11 | | assistant's supervising physician has delegated the
provision |
12 | | of AIDS and
HIV-related health services, (iii) an advanced |
13 | | practice registered nurse who
has a written
collaborative |
14 | | agreement with a collaborating physician which authorizes the
|
15 | | provision of AIDS
and HIV-related health services, (iv) an |
16 | | advanced practice nurse or physician assistant who practices in |
17 | | a hospital or ambulatory surgical treatment center and |
18 | | possesses appropriate clinical privileges, (v) a licensed |
19 | | dentist, (vi) (v) a licensed podiatric physician, or (vii) (vi) |
20 | | an
individual certified to provide HIV testing and counseling |
21 | | by a state or local
public health
department. |
22 | | (j) "Health care provider" has the meaning ascribed to it |
23 | | under HIPAA, as specified in 45 CFR 160.103.
|
24 | | (k) "Health facility" means a hospital, nursing home, blood |
25 | | bank, blood
center, sperm bank, or other health care |
26 | | institution, including any "health
facility" as that term is |
|
| | 09900HB1431ham001 | - 3 - | LRB099 07179 JLK 32896 a |
|
|
1 | | defined in the Illinois Finance Authority
Act.
|
2 | | (l) "Health information exchange" or "HIE" means a health |
3 | | information exchange or health information organization that |
4 | | oversees and governs the electronic exchange of health |
5 | | information that (i) is established pursuant to the Illinois |
6 | | Health Information Exchange and Technology Act, or any |
7 | | subsequent amendments thereto, and any administrative rules |
8 | | adopted thereunder; (ii) has established a data sharing |
9 | | arrangement with the Authority; or (iii) as of August 16, 2013, |
10 | | was designated by the Authority Board as a member of, or was |
11 | | represented on, the Authority Board's Regional Health |
12 | | Information Exchange Workgroup; provided that such designation
|
13 | | shall not require the establishment of a data sharing |
14 | | arrangement or other participation with the Illinois Health
|
15 | | Information Exchange or the payment of any fee. In certain |
16 | | circumstances, in accordance with HIPAA, an HIE will be a |
17 | | business associate. |
18 | | (m) "Health oversight agency" has the meaning ascribed to |
19 | | it under HIPAA, as specified in 45 CFR 164.501. |
20 | | (n) "HIPAA" means the Health Insurance Portability and |
21 | | Accountability Act of 1996, Public Law 104-191, as amended by |
22 | | the Health Information Technology for Economic and Clinical |
23 | | Health Act of 2009, Public Law 111-05, and any subsequent |
24 | | amendments thereto and any regulations promulgated thereunder. |
25 | | (o) "HIV" means the human immunodeficiency virus. |
26 | | (p) "HIV-related information" means the identity of a |
|
| | 09900HB1431ham001 | - 4 - | LRB099 07179 JLK 32896 a |
|
|
1 | | person upon whom an HIV test is performed, the results of an |
2 | | HIV test, as well as diagnosis, treatment, and prescription |
3 | | information that reveals a patient is HIV-positive, including |
4 | | such information contained in a limited data set. "HIV-related |
5 | | information" does not include information that has been |
6 | | de-identified in accordance with HIPAA. |
7 | | (q) "Informed consent" means : |
8 | | (1) a process by which an individual or their legal |
9 | | representative receives pre-test information, has an |
10 | | opportunity to ask questions, and consents verbally or in |
11 | | writing to the test; or |
12 | | (2) where a health facility has implemented opt-out |
13 | | testing, the individual or their legal representative has |
14 | | received pre-test information and been given the |
15 | | opportunity to ask questions and the opportunity to decline |
16 | | testing, and has not declined testing. a written or verbal
|
17 | | agreement by the subject of a test or the subject's
legally |
18 | | authorized representative without undue inducement or any |
19 | | element
of force, fraud, deceit, duress, or other form of |
20 | | constraint or coercion,
which entails at least the |
21 | | following pre-test information: |
22 | | (1) a fair explanation of the test, including its |
23 | | purpose, potential
uses, limitations, and the meaning of |
24 | | its results; |
25 | | (2) a fair explanation of the procedures to be |
26 | | followed, including the
voluntary nature of the test, the |
|
| | 09900HB1431ham001 | - 5 - | LRB099 07179 JLK 32896 a |
|
|
1 | | right to withdraw consent to the testing
process at any |
2 | | time, the right to anonymity to the extent provided by law
|
3 | | with respect to participation in the test and disclosure of |
4 | | test results,
and the right to confidential treatment of
|
5 | | information identifying the subject of the test and the |
6 | | results of the
test, to the extent provided by law; and |
7 | | In addition, (3) where the person providing informed |
8 | | consent is a participant in an HIE, informed consent requires a |
9 | | fair explanation that the results of the patient's HIV test |
10 | | will be accessible through an HIE and meaningful disclosure of |
11 | | the patient's opt-out right under Section 9.6 of this Act. |
12 | | Consent must occur without undue inducement or any element |
13 | | of force, fraud, deceit, duress, or other form of constraint or |
14 | | coercion. |
15 | | A Pre-test information may be provided in writing, |
16 | | verbally, or by video, electronic, or other means. The subject |
17 | | must be offered an opportunity to ask questions about the HIV |
18 | | test and decline testing. Nothing in this Act shall prohibit a |
19 | | health care provider , or health care professional , or health |
20 | | facility may combine from combining a form used to obtain |
21 | | informed consent for HIV testing with forms used to obtain |
22 | | written consent for general medical care or any other medical |
23 | | test or procedure provided that the forms make it clear that |
24 | | the subject may consent to general medical care, tests, or |
25 | | medical procedures without being required to consent to HIV |
26 | | testing and clearly explain how the subject may opt out of HIV |
|
| | 09900HB1431ham001 | - 6 - | LRB099 07179 JLK 32896 a |
|
|
1 | | testing. Health facility clerical staff responsible for the |
2 | | consent form for general medical care may obtain consent for |
3 | | HIV testing through a general consent form. |
4 | | (r) "Limited data set" has the meaning ascribed to it under |
5 | | HIPAA, as described in 45 CFR 164.514(e)(2). |
6 | | (s) "Minimum necessary" means the HIPAA standard for using, |
7 | | disclosing, and requesting protected health information found |
8 | | in 45 CFR 164.502(b) and 164.514(d). |
9 | | (t) "Organized health care arrangement" has the meaning |
10 | | ascribed to it under HIPAA, as specified in 45 CFR 160.103. |
11 | | (u) "Patient safety activities" has the meaning ascribed to |
12 | | it under 42 CFR 3.20. |
13 | | (v) "Payment" has the meaning ascribed to it under HIPAA, |
14 | | as specified in 45 CFR 164.501. |
15 | | (w) "Person" includes any natural person, partnership, |
16 | | association, joint venture, trust, governmental entity, public |
17 | | or private corporation, health facility, or other legal entity. |
18 | | (w-5) "Pre-test information" means: |
19 | | (1) a reasonable explanation of the test, including its |
20 | | purpose, potential uses, limitations, and the meaning of |
21 | | its results; and |
22 | | (2) a reasonable explanation of the procedures to be |
23 | | followed, including the voluntary nature of the test, the |
24 | | availability of an appropriate person to answer questions, |
25 | | the right to withdraw consent to the testing process at any |
26 | | time, the right to anonymity to the extent provided by law |
|
| | 09900HB1431ham001 | - 7 - | LRB099 07179 JLK 32896 a |
|
|
1 | | with respect to participation in the test and disclosure of |
2 | | test results, and the right to confidential treatment of |
3 | | information identifying the subject of the test and the |
4 | | results of the test, to the extent provided by law. |
5 | | The pre-test information required as part of the informed |
6 | | consent may be provided in writing, verbally, or by video, |
7 | | electronic, or other means and may be provided as designated by |
8 | | the supervising health care professional or the health |
9 | | facility. For the purposes of this definition and Section 5 of |
10 | | this Act, an appropriate person to answer questions is someone |
11 | | determined to be sufficiently knowledgeable in the |
12 | | professional judgment of a supervising health care |
13 | | professional or as designated by a health facility. |
14 | | (x) "Protected health information" has the meaning |
15 | | ascribed to it under HIPAA, as specified in 45 CFR 160.103. |
16 | | (y) "Research" has the meaning ascribed to it under HIPAA, |
17 | | as specified in 45 CFR 164.501. |
18 | | (z) "State agency" means an instrumentality of the State of |
19 | | Illinois and any instrumentality of another state that, |
20 | | pursuant to applicable law or a written undertaking with an |
21 | | instrumentality of the State of Illinois, is bound to protect |
22 | | the privacy of HIV-related information of Illinois persons.
|
23 | | (aa) "Test" or "HIV test" means a test to determine the |
24 | | presence of the
antibody or antigen to HIV, or of HIV |
25 | | infection.
|
26 | | (bb) "Treatment" has the meaning ascribed to it under |
|
| | 09900HB1431ham001 | - 8 - | LRB099 07179 JLK 32896 a |
|
|
1 | | HIPAA, as specified in 45 CFR 164.501. |
2 | | (cc) "Use" has the meaning ascribed to it under HIPAA, as |
3 | | specified in 45 CFR 160.103, where context dictates.
|
4 | | (Source: P.A. 98-214, eff. 8-9-13; 98-1046, eff. 1-1-15 .)
|
5 | | (410 ILCS 305/4) (from Ch. 111 1/2, par. 7304)
|
6 | | Sec. 4. Informed consent. No person may order an HIV test |
7 | | without first receiving
the documented informed consent
of the |
8 | | subject of the test or the subject's legally authorized
|
9 | | representative. A health care facility or provider may provide |
10 | | offer opt-out HIV testing where the subject or the subject's |
11 | | legally authorized representative is informed that the subject |
12 | | may will be tested for HIV unless he or she refuses. The |
13 | | subject's or the subject's legally authorized representative's |
14 | | verbal or written consent, or declination of opt-out HIV |
15 | | testing, must be documented by the health facility or provider |
16 | | in the general consent for medical care, a separate consent |
17 | | form, or elsewhere in the medical record. The health care |
18 | | facility or provider must document the provision of informed |
19 | | consent, including pre-test information, and whether the |
20 | | subject or the subject's legally authorized representative |
21 | | declined the offer of HIV testing.
|
22 | | (Source: P.A. 95-7, eff. 6-1-08 .)
|
23 | | (410 ILCS 305/5 rep.) |
24 | | Section 10. The AIDS Confidentiality Act is amended by |